DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
Glufosfamide is an investigational drug.
There have been 9 clinical trials for Glufosfamide. The most recent clinical trial was a Phase 3 trial, which was initiated on September 1st 2013.
The most common disease conditions in clinical trials are Pancreatic Neoplasms, Lung Neoplasms, and Glioblastoma. The leading clinical trial sponsors are Threshold Pharmaceuticals, Eleison Pharmaceuticals LLC., and European Organisation for Research and Treatment of Cancer - EORTC.
Recent Clinical Trials for Glufosfamide
|Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer||Eleison Pharmaceuticals LLC.||Phase 3|
|Safety and Efficacy Study of Glufosfamide in Previously Treated Advanced Soft Tissue Sarcoma||Threshold Pharmaceuticals||Phase 2|
|Safety and Efficacy Study of Glufosfamide in Previously Treated Advanced Soft Tissue Sarcoma||Eleison Pharmaceuticals LLC.||Phase 2|